These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37231818)

  • 1. Soluble CD14 and Osteoprotegerin Associate with Ankle-Brachial Index as a Measure of Arterial Stiffness in Patients with Mild-to-Moderate Chronic Kidney Disease in a Five-Year Prospective Study.
    Sendic S; Mansouri L; Hong MG; Schwenk JM; Eriksson MJ; Hylander B; Lundahl J; Jacobson SH
    Cardiorenal Med; 2023; 13(1):189-201. PubMed ID: 37231818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular changes in patients with mild-to-moderate chronic kidney disease compared with healthy subjects: a 5-year follow-up study.
    Asp AM; Wallquist C; Rickenlund A; Hylander B; Jacobson SH; Caidahl K; Eriksson MJ
    Clin Physiol Funct Imaging; 2020 Mar; 40(2):91-98. PubMed ID: 31701609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3-5.
    Marques GL; Hayashi S; Bjällmark A; Larsson M; Riella M; Olandoski M; Lindholm B; Nascimento MM
    Sci Rep; 2021 Jan; 11(1):2473. PubMed ID: 33510348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients.
    Kim HR; Kim SH; Han MJ; Yoon YS; Oh DJ
    Nephron Clin Pract; 2013; 123(3-4):165-72. PubMed ID: 23921088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Correlation of Serum Osteoprotegerin with Non-Traditional Cardiovascular Risk Factors and Arterial Stiffness in Patients with Pre-Dialysis Chronic Kidney Disease: Results from the KNOW-CKD Study.
    Chae SY; Chung W; Kim YH; Oh YK; Lee J; Choi KH; Ahn C; Kim YS
    J Korean Med Sci; 2018 Dec; 33(53):e322. PubMed ID: 30595681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study.
    Arroyo D; Betriu A; Valls J; Gorriz JL; Pallares V; Abajo M; Gracia M; Valdivielso JM; Fernandez E;
    Nephrol Dial Transplant; 2017 Mar; 32(3):513-520. PubMed ID: 27190385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.
    Poesen R; Ramezani A; Claes K; Augustijns P; Kuypers D; Barrows IR; Muralidharan J; Evenepoel P; Meijers B; Raj DS
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1525-33. PubMed ID: 26153127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification.
    Krzanowski M; Krzanowska K; Dumnicka P; Gajda M; Woziwodzka K; Fedak D; Grodzicki T; Litwin JA; Sułowicz W
    Ther Apher Dial; 2018 Oct; 22(5):519-529. PubMed ID: 29974642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high normal ankle-brachial index is associated with biopsy-proven severe renal small artery intimal thickening and impaired renal function in chronic kidney disease.
    Zamami R; Ishida A; Miyagi T; Yamazato M; Kohagura K; Ohya Y
    Hypertens Res; 2020 Sep; 43(9):929-937. PubMed ID: 32346139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients.
    Nakashima A; Carrero JJ; Qureshi AR; Hirai T; Takasugi N; Ueno T; Taniguchi Y; Lindholm B; Yorioka N
    Osteoporos Int; 2011 Jun; 22(6):1695-701. PubMed ID: 20812007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
    Fernández-Laso V; Sastre C; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):413-22. PubMed ID: 26728587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of ankle-brachial index to all-cause mortality and cardiovascular mortality in Chinese patients with chronic kidney disease.
    Wang Y; Guo X; Li J; Hu D; Zhao D; Ma H; Mou Q; Liu J; Xu Y
    Vasa; 2012 May; 41(3):205-13. PubMed ID: 22565622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Serum Osteoprotegerin With Vascular Calcification, and Cardiovascular and Graft Outcomes in Kidney Transplant Patients: Results From the KNOW-KT.
    Jeon HJ; Ryu JH; Kim MG; Huh KH; Lee KW; Kim CD; Kang KP; Ro H; Han S; Yang J;
    Transplantation; 2024 May; 108(5):1239-1248. PubMed ID: 38291579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study.
    Arroyo D; Betriu A; Martinez-Alonso M; Vidal T; Valdivielso JM; Fernández E;
    BMC Nephrol; 2014 Oct; 15():168. PubMed ID: 25326683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum osteoprotegerin level is positively associated with peripheral artery disease in patients with peritoneal dialysis.
    Lin WC; Tsai JP; Lai YH; Lin YL; Kuo CH; Wang CH; Hsu BG
    Ren Fail; 2020 Nov; 42(1):131-136. PubMed ID: 31950864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients.
    Bernardi S; Toffoli B; Bossi F; Candido R; Stenner E; Carretta R; Barbone F; Fabris B
    BMC Nephrol; 2017 Jul; 18(1):219. PubMed ID: 28683789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild chronic kidney disease associated with greater risk of arterial stiffness in elderly adults.
    Liu IT; Wu JS; Yang YC; Huang YH; Lu FH; Chang CJ
    J Am Geriatr Soc; 2013 Oct; 61(10):1758-62. PubMed ID: 24083328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease.
    Bozic M; Méndez-Barbero N; Gutiérrez-Muñoz C; Betriu A; Egido J; Fernández E; Martín-Ventura JL; Valdivielso JM; Blanco-Colio LM;
    Atherosclerosis; 2018 Mar; 270():13-20. PubMed ID: 29407881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease.
    Anguiano L; Riera M; Pascual J; Valdivielso JM; Barrios C; Betriu A; Clotet S; Mojal S; Fernández E; Soler MJ;
    Atherosclerosis; 2016 Oct; 253():135-143. PubMed ID: 27615597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in FGF-23, Neutrophil/Platelet Activation Markers, and Angiogenin in Advanced Chronic Kidney Disease and Their Effect on Arterial Stiffness.
    Choi HM; Kwon YE; Kim S; Oh DJ
    Kidney Blood Press Res; 2019; 44(5):1166-1178. PubMed ID: 31553973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.